Translational Development Acquisition Corp.

TDAC | NASDAQ

$10.87

+$0.02 (+0.18%)

At close: Sep 21, 2026, 4:00 PM ET

$10.87

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022
Revenue	n/a	1.07M	n/a	n/a
Cost of Revenue	n/a	320.87K	n/a	n/a
Gross Profit	n/a	744.92K	n/a	n/a
Operating Income	-944.54K	-196.36K	-485.55K	-70.66K
Interest Income	n/a	n/a	n/a	n/a
Pretax Income	6.36M	-71.01K	-485.55K	-70.66K
Net Income	6.36M	-71.01K	-485.55K	-70.66K
Selling & General & Admin	944.54K	196.36K	485.55K	70.66K
Research & Development	n/a	n/a	n/a	n/a
Other Expenses	n/a	n/a	n/a	n/a
Operating Expenses	944.54K	196.36K	485.55K	70.66K
Interest Expense	n/a	508.56K	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a
Cost & Expenses	944.54K	-196.36K	485.55K	70.66K
Income Tax Expense	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	17.25M	4.05M	4.05M	4.05M
Shares Outstanding (Diluted)	17.25M	4.05M	4.05M	4.05M
EPS (Basic)	0.37	-0.02	-0.12	-0.02
EPS (Diluted)	0.37	-0.02	-0.12	-0.02
EBITDA	-944.54K	-71.01K	-485.55K	n/a
EBIT	-944.54K	-71.01K	-485.55K	-70.66K
Depreciation & Amortization	n/a	n/a	n/a	70.66K